 | • レポートコード：GIR201105925 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、核内受容体ROR-ガンマの世界市場を調査対象にし、核内受容体ROR-ガンマの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（VPR-66、INV-17、GSK-2981278、BBI-6000、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：4SC AG、Celgene Corporation、Aurigene Discovery Technologies Limited、Advinus Therapeutics Ltd.、Bristol-Myers Squibb Company、Arrien Pharmaceuticals, LLC、Genfit SA、Brickell Biotech, Inc.、Biogen, Inc.、Genentech, Inc.、Nuevolution AB、Teijin Pharma Limited、GlaxoSmithKline Plc、Vitae Pharmaceuticals, Inc.、Phenex Pharmaceuticals AG、Lead Pharma Holding B.V.、Hanmi Pharmaceuticals, Co. Ltd.、Visionary Pharmaceuticals, Inc.、Reata Pharmaceuticals, Inc.、Karo Bio AB ・メーカー別販売量、売上、市場シェア ・核内受容体ROR-ガンマの地域別市場分析 ・核内受容体ROR-ガンマの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・核内受容体ROR-ガンマのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・核内受容体ROR-ガンマのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・核内受容体ROR-ガンマの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・核内受容体ROR-ガンマの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・核内受容体ROR-ガンマの種類別市場規模2015-2020：VPR-66、INV-17、GSK-2981278、BBI-6000、その他 ・核内受容体ROR-ガンマの用途別市場規模2015-2020：病院、クリニック、その他 ・核内受容体ROR-ガンマの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Nuclear Receptor ROR-Gamma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nuclear Receptor ROR-Gamma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Receptor ROR-Gamma market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Receptor ROR-Gamma market has been segmented into
VPR-66
INV-17
GSK-2981278
BBI-6000
Others
By Application, Nuclear Receptor ROR-Gamma has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Receptor ROR-Gamma market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Receptor ROR-Gamma markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Receptor ROR-Gamma market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Receptor ROR-Gamma market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Receptor ROR-Gamma Market Share Analysis
Nuclear Receptor ROR-Gamma competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Receptor ROR-Gamma sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Receptor ROR-Gamma sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Receptor ROR-Gamma are:
4SC AG
Celgene Corporation
Aurigene Discovery Technologies Limited
Advinus Therapeutics Ltd.
Bristol-Myers Squibb Company
Arrien Pharmaceuticals, LLC
Genfit SA
Brickell Biotech, Inc.
Biogen, Inc.
Genentech, Inc.
Nuevolution AB
Teijin Pharma Limited
GlaxoSmithKline Plc
Vitae Pharmaceuticals, Inc.
Phenex Pharmaceuticals AG
Lead Pharma Holding B.V.
Hanmi Pharmaceuticals, Co. Ltd.
Visionary Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Karo Bio AB
Among other players domestic and global, Nuclear Receptor ROR-Gamma market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Receptor ROR-Gamma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Receptor ROR-Gamma, with price, sales, revenue and global market share of Nuclear Receptor ROR-Gamma in 2018 and 2019.
Chapter 3, the Nuclear Receptor ROR-Gamma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Receptor ROR-Gamma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Receptor ROR-Gamma market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Receptor ROR-Gamma sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nuclear Receptor ROR-Gamma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 VPR-66
1.2.3 INV-17
1.2.4 GSK-2981278
1.2.5 BBI-6000
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Receptor ROR-Gamma Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Nuclear Receptor ROR-Gamma Market
1.4.1 Global Nuclear Receptor ROR-Gamma Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 4SC AG Details
2.1.2 4SC AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 4SC AG SWOT Analysis
2.1.4 4SC AG Product and Services
2.1.5 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celgene Corporation
2.2.1 Celgene Corporation Details
2.2.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celgene Corporation SWOT Analysis
2.2.4 Celgene Corporation Product and Services
2.2.5 Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aurigene Discovery Technologies Limited
2.3.1 Aurigene Discovery Technologies Limited Details
2.3.2 Aurigene Discovery Technologies Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aurigene Discovery Technologies Limited SWOT Analysis
2.3.4 Aurigene Discovery Technologies Limited Product and Services
2.3.5 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advinus Therapeutics Ltd.
2.4.1 Advinus Therapeutics Ltd. Details
2.4.2 Advinus Therapeutics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advinus Therapeutics Ltd. SWOT Analysis
2.4.4 Advinus Therapeutics Ltd. Product and Services
2.4.5 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb Company SWOT Analysis
2.5.4 Bristol-Myers Squibb Company Product and Services
2.5.5 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Arrien Pharmaceuticals, LLC
2.6.1 Arrien Pharmaceuticals, LLC Details
2.6.2 Arrien Pharmaceuticals, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Arrien Pharmaceuticals, LLC SWOT Analysis
2.6.4 Arrien Pharmaceuticals, LLC Product and Services
2.6.5 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Genfit SA
2.7.1 Genfit SA Details
2.7.2 Genfit SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Genfit SA SWOT Analysis
2.7.4 Genfit SA Product and Services
2.7.5 Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Brickell Biotech, Inc.
2.8.1 Brickell Biotech, Inc. Details
2.8.2 Brickell Biotech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Brickell Biotech, Inc. SWOT Analysis
2.8.4 Brickell Biotech, Inc. Product and Services
2.8.5 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biogen, Inc.
2.9.1 Biogen, Inc. Details
2.9.2 Biogen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biogen, Inc. SWOT Analysis
2.9.4 Biogen, Inc. Product and Services
2.9.5 Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Genentech, Inc.
2.10.1 Genentech, Inc. Details
2.10.2 Genentech, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Genentech, Inc. SWOT Analysis
2.10.4 Genentech, Inc. Product and Services
2.10.5 Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Nuevolution AB
2.11.1 Nuevolution AB Details
2.11.2 Nuevolution AB Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Nuevolution AB SWOT Analysis
2.11.4 Nuevolution AB Product and Services
2.11.5 Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teijin Pharma Limited
2.12.1 Teijin Pharma Limited Details
2.12.2 Teijin Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teijin Pharma Limited SWOT Analysis
2.12.4 Teijin Pharma Limited Product and Services
2.12.5 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 GlaxoSmithKline Plc
2.13.1 GlaxoSmithKline Plc Details
2.13.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GlaxoSmithKline Plc SWOT Analysis
2.13.4 GlaxoSmithKline Plc Product and Services
2.13.5 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Vitae Pharmaceuticals, Inc.
2.14.1 Vitae Pharmaceuticals, Inc. Details
2.14.2 Vitae Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Vitae Pharmaceuticals, Inc. SWOT Analysis
2.14.4 Vitae Pharmaceuticals, Inc. Product and Services
2.14.5 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Phenex Pharmaceuticals AG
2.15.1 Phenex Pharmaceuticals AG Details
2.15.2 Phenex Pharmaceuticals AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Phenex Pharmaceuticals AG SWOT Analysis
2.15.4 Phenex Pharmaceuticals AG Product and Services
2.15.5 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Lead Pharma Holding B.V.
2.16.1 Lead Pharma Holding B.V. Details
2.16.2 Lead Pharma Holding B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Lead Pharma Holding B.V. SWOT Analysis
2.16.4 Lead Pharma Holding B.V. Product and Services
2.16.5 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hanmi Pharmaceuticals, Co. Ltd.
2.17.1 Hanmi Pharmaceuticals, Co. Ltd. Details
2.17.2 Hanmi Pharmaceuticals, Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
2.17.4 Hanmi Pharmaceuticals, Co. Ltd. Product and Services
2.17.5 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Visionary Pharmaceuticals, Inc.
2.18.1 Visionary Pharmaceuticals, Inc. Details
2.18.2 Visionary Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Visionary Pharmaceuticals, Inc. SWOT Analysis
2.18.4 Visionary Pharmaceuticals, Inc. Product and Services
2.18.5 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Reata Pharmaceuticals, Inc.
2.19.1 Reata Pharmaceuticals, Inc. Details
2.19.2 Reata Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Reata Pharmaceuticals, Inc. SWOT Analysis
2.19.4 Reata Pharmaceuticals, Inc. Product and Services
2.19.5 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Karo Bio AB
2.20.1 Karo Bio AB Details
2.20.2 Karo Bio AB Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Karo Bio AB SWOT Analysis
2.20.4 Karo Bio AB Product and Services
2.20.5 Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Receptor ROR-Gamma Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.4 France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.5 India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Receptor ROR-Gamma Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Receptor ROR-Gamma Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Receptor ROR-Gamma Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Receptor ROR-Gamma Price by Type (2015-2020)
11 Global Nuclear Receptor ROR-Gamma Market Segment by Application
11.1 Global Nuclear Receptor ROR-Gamma Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Receptor ROR-Gamma Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Receptor ROR-Gamma Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Receptor ROR-Gamma Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.2 Europe Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.4 South America Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Receptor ROR-Gamma Market Forecast (2021-2025)
12.3 Nuclear Receptor ROR-Gamma Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2021-2025)
12.4 Nuclear Receptor ROR-Gamma Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nuclear Receptor ROR-Gamma Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Receptor ROR-Gamma by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Receptor ROR-Gamma Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. 4SC AG Basic Information, Manufacturing Base and Competitors
Table 8. 4SC AG Nuclear Receptor ROR-Gamma Major Business
Table 9. 4SC AG Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 10. 4SC AG SWOT Analysis
Table 11. 4SC AG Nuclear Receptor ROR-Gamma Product and Services
Table 12. 4SC AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Celgene Corporation Nuclear Receptor ROR-Gamma Major Business
Table 15. Celgene Corporation Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 16. Celgene Corporation SWOT Analysis
Table 17. Celgene Corporation Nuclear Receptor ROR-Gamma Product and Services
Table 18. Celgene Corporation Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Aurigene Discovery Technologies Limited Basic Information, Manufacturing Base and Competitors
Table 20. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Major Business
Table 21. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 22. Aurigene Discovery Technologies Limited SWOT Analysis
Table 23. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product and Services
Table 24. Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Advinus Therapeutics Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Major Business
Table 27. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 28. Advinus Therapeutics Ltd. SWOT Analysis
Table 29. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product and Services
Table 30. Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Major Business
Table 33. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 34. Bristol-Myers Squibb Company SWOT Analysis
Table 35. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product and Services
Table 36. Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Arrien Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 38. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Major Business
Table 39. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 40. Arrien Pharmaceuticals, LLC SWOT Analysis
Table 41. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product and Services
Table 42. Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Genfit SA Basic Information, Manufacturing Base and Competitors
Table 44. Genfit SA Nuclear Receptor ROR-Gamma Major Business
Table 45. Genfit SA Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 46. Genfit SA SWOT Analysis
Table 47. Genfit SA Nuclear Receptor ROR-Gamma Product and Services
Table 48. Genfit SA Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Brickell Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 51. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 52. Brickell Biotech, Inc. SWOT Analysis
Table 53. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 54. Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Biogen, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 57. Biogen, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 58. Biogen, Inc. SWOT Analysis
Table 59. Biogen, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 60. Biogen, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Genentech, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 63. Genentech, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 64. Genentech, Inc. SWOT Analysis
Table 65. Genentech, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 66. Genentech, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Nuevolution AB Basic Information, Manufacturing Base and Competitors
Table 68. Nuevolution AB Nuclear Receptor ROR-Gamma Major Business
Table 69. Nuevolution AB Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 70. Nuevolution AB SWOT Analysis
Table 71. Nuevolution AB Nuclear Receptor ROR-Gamma Product and Services
Table 72. Nuevolution AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Teijin Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 74. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Major Business
Table 75. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 76. Teijin Pharma Limited SWOT Analysis
Table 77. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product and Services
Table 78. Teijin Pharma Limited Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 80. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Major Business
Table 81. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 82. GlaxoSmithKline Plc SWOT Analysis
Table 83. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product and Services
Table 84. GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Vitae Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 87. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 88. Vitae Pharmaceuticals, Inc. SWOT Analysis
Table 89. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 90. Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Phenex Pharmaceuticals AG Basic Information, Manufacturing Base and Competitors
Table 92. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Major Business
Table 93. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 94. Phenex Pharmaceuticals AG SWOT Analysis
Table 95. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product and Services
Table 96. Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Lead Pharma Holding B.V. Basic Information, Manufacturing Base and Competitors
Table 98. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Major Business
Table 99. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 100. Lead Pharma Holding B.V. SWOT Analysis
Table 101. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product and Services
Table 102. Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Hanmi Pharmaceuticals, Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Major Business
Table 105. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 106. Hanmi Pharmaceuticals, Co. Ltd. SWOT Analysis
Table 107. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product and Services
Table 108. Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Type and Application
Table 110. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 111. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 112. Visionary Pharmaceuticals, Inc. SWOT Analysis
Table 113. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 114. Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Reata Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Major Business
Table 117. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 118. Reata Pharmaceuticals, Inc. SWOT Analysis
Table 119. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product and Services
Table 120. Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Karo Bio AB Basic Information, Manufacturing Base and Competitors
Table 122. Karo Bio AB Nuclear Receptor ROR-Gamma Major Business
Table 123. Karo Bio AB Nuclear Receptor ROR-Gamma Total Revenue (USD Million) (2018-2019)
Table 124. Karo Bio AB SWOT Analysis
Table 125. Karo Bio AB Nuclear Receptor ROR-Gamma Product and Services
Table 126. Karo Bio AB Nuclear Receptor ROR-Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Global Nuclear Receptor ROR-Gamma Sales by Manufacturer (2018-2019) (K Pcs)
Table 128. Global Nuclear Receptor ROR-Gamma Revenue by Manufacturer (2018-2019) (USD Million)
Table 129. Global Nuclear Receptor ROR-Gamma Sales by Regions (2015-2020) (K Pcs)
Table 130. Global Nuclear Receptor ROR-Gamma Sales Market Share by Regions (2015-2020)
Table 131. Global Nuclear Receptor ROR-Gamma Revenue by Regions (2015-2020) (USD Million)
Table 132. North America Nuclear Receptor ROR-Gamma Sales by Countries (2015-2020) (K Pcs)
Table 133. North America Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2015-2020)
Table 134. North America Nuclear Receptor ROR-Gamma Revenue by Countries (2015-2020) (USD Million)
Table 135. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020)
Table 136. Europe Nuclear Receptor ROR-Gamma Sales by Countries (2015-2020) (K Pcs)
Table 137. Europe Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2015-2020)
Table 138. Europe Nuclear Receptor ROR-Gamma Revenue by Countries (2015-2020) (USD Million)
Table 139. Asia-Pacific Nuclear Receptor ROR-Gamma Sales by Regions (2015-2020) (K Pcs)
Table 140. Asia-Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Regions (2015-2020)
Table 141. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue by Regions (2015-2020) (USD Million)
Table 142. South America Nuclear Receptor ROR-Gamma Sales by Countries (2015-2020) (K Pcs)
Table 143. South America Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2015-2020)
Table 144. South America Nuclear Receptor ROR-Gamma Revenue by Countries (2015-2020) (USD Million)
Table 145. South America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020)
Table 146. Middle East & Africa Nuclear Receptor ROR-Gamma Sales by Countries (2015-2020) (K Pcs)
Table 147. Middle East & Africa Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2015-2020)
Table 148. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue by Countries (2015-2020) (USD Million)
Table 149. Middle East & Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020)
Table 150. Global Nuclear Receptor ROR-Gamma Sales by Type (2015-2020) (K Pcs)
Table 151. Global Nuclear Receptor ROR-Gamma Sales Share by Type (2015-2020)
Table 152. Global Nuclear Receptor ROR-Gamma Revenue by Type (2015-2020) (USD Million)
Table 153. Global Nuclear Receptor ROR-Gamma Revenue Share by Type (2015-2020)
Table 154. Global Nuclear Receptor ROR-Gamma Sales by Application (2015-2020) (K Pcs)
Table 155. Global Nuclear Receptor ROR-Gamma Sales Share by Application (2015-2020)
Table 156. Global Nuclear Receptor ROR-Gamma Sales Forecast by Regions (2021-2025) (K Pcs)
Table 157. Global Nuclear Receptor ROR-Gamma Market Share Forecast by Regions (2021-2025)
Table 158. Global Nuclear Receptor ROR-Gamma Sales Forecast by Type (2021-2025) (K Pcs)
Table 159. Global Nuclear Receptor ROR-Gamma Market Share Forecast by Type (2021-2025)
Table 160. Global Nuclear Receptor ROR-Gamma Sales Forecast by Application (2021-2025)
Table 161. Global Nuclear Receptor ROR-Gamma Market Share Forecast by Application (2021-2025)
Table 162. Direct Channel Pros & Cons
Table 163. Indirect Channel Pros & Cons
Table 164. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nuclear Receptor ROR-Gamma Picture
Figure 2. Global Sales Market Share of Nuclear Receptor ROR-Gamma by Type in 2019
Figure 3. VPR-66 Picture
Figure 4. INV-17 Picture
Figure 5. GSK-2981278 Picture
Figure 6. BBI-6000 Picture
Figure 7. Others Picture
Figure 8. Nuclear Receptor ROR-Gamma Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Nuclear Receptor ROR-Gamma Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Nuclear Receptor ROR-Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Nuclear Receptor ROR-Gamma Sales Market Share by Manufacturer in 2019
Figure 33. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Nuclear Receptor ROR-Gamma Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Nuclear Receptor ROR-Gamma Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Regions (2015-2020)
Figure 40. Global Nuclear Receptor ROR-Gamma Revenue Market Share by Regions in 2018
Figure 41. North America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
Figure 42. Europe Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
Figure 44. South America Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020)
Figure 46. North America Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Nuclear Receptor ROR-Gamma Sales Market Share by Countries (2015-2020)
Figure 48. North America Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2018
Figure 49. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2018
Figure 51. United States Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2019
Figure 57. Germany Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Nuclear Receptor ROR-Gamma Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Nuclear Receptor ROR-Gamma Revenue Market Share by Regions 2019
Figure 65. China Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2019
Figure 72. South America Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2019
Figure 73. Brazil Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Nuclear Receptor ROR-Gamma Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Nuclear Receptor ROR-Gamma Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Nuclear Receptor ROR-Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Nuclear Receptor ROR-Gamma Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Nuclear Receptor ROR-Gamma Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Nuclear Receptor ROR-Gamma Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Nuclear Receptor ROR-Gamma Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Nuclear Receptor ROR-Gamma Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Nuclear Receptor ROR-Gamma Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Nuclear Receptor ROR-Gamma Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場 2020年 Market Overview The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million …- ガンマアミノ酪酸受容体サブユニットガンマ2の世界市場 2020年 Market Overview The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- タンパク質グルタミンガンマグルタミルトランスフェラーゼ2の世界市場 2020年 Market Overview The global Protein Glutamine Gamma Glutamyltransferase 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…
- 600 MHz核磁気共鳴分光計の世界市場 2020年 Market Overview The 600 MHz Nuclear Magnetic Resonance Spectrometer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…
- ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…